Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 10.988.726.2411.727.91

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 10.98 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202410.98
Mar20238.72
Mar20226.24
Mar202111.72
Mar20207.91

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 10.98
25.92
Mar2023 8.72
39.74
Mar2022 6.24
-46.76
Mar2021 11.72
48.17
Mar2020 7.91 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹384.0 Cr -1.9% -3.6% -20.8% Stock Analytics
ADANI ENTERPRISES ₹269,905.0 Cr 3.4% -1.5% -28.4% Stock Analytics
REDINGTON ₹18,117.6 Cr 13.8% 13.6% 17.9% Stock Analytics
MMTC ₹10,006.5 Cr 0.6% -5% -28.7% Stock Analytics
HONASA CONSUMER ₹6,959.4 Cr -4.6% -11.4% -48.8% Stock Analytics
MSTC ₹4,068.4 Cr -0.6% -8.4% -46.3% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-1.9%

-3.6%

-20.8%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses